2023
DOI: 10.1038/s41467-023-40242-9
|View full text |Cite
|
Sign up to set email alerts
|

A tripartite microbial co-culture system for de novo biosynthesis of diverse plant phenylpropanoids

Abstract: Plant-derived phenylpropanoids, in particular phenylpropenes, have diverse industrial applications ranging from flavors and fragrances to polymers and pharmaceuticals. Heterologous biosynthesis of these products has the potential to address low, seasonally dependent yields hindering ease of widespread manufacturing. However, previous efforts have been hindered by the inherent pathway promiscuity and the microbial toxicity of key pathway intermediates. Here, in this study, we establish the propensity of a tripa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
3
0

Year Published

2024
2024
2025
2025

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(7 citation statements)
references
References 46 publications
0
3
0
Order By: Relevance
“…In addition, mutualistic consortia also endow microorganisms with higher synthetic titres through unique abilities, such as balancing metabolic flow, relieving metabolic burden, optimising resource utilisation, enriching the cellular environment and cofactors, and adapting to fluctuating environments. Considering these advantages, microbial consortium strategies have been extended to construct bacterial, yeast, and yeast systems for the synthesis of terpenoids, 214 phenylpropanoids, 215,216 and polyketones, 217 and alkaloids. 218 However, most are simply mixed cultures formed by changing the initial inoculation ratio, 219 which makes it difficult to form a stable community, and this instability is further amplified in large-scale fermentation.…”
Section: Discussion and Future Perspectivesmentioning
confidence: 99%
See 1 more Smart Citation
“…In addition, mutualistic consortia also endow microorganisms with higher synthetic titres through unique abilities, such as balancing metabolic flow, relieving metabolic burden, optimising resource utilisation, enriching the cellular environment and cofactors, and adapting to fluctuating environments. Considering these advantages, microbial consortium strategies have been extended to construct bacterial, yeast, and yeast systems for the synthesis of terpenoids, 214 phenylpropanoids, 215,216 and polyketones, 217 and alkaloids. 218 However, most are simply mixed cultures formed by changing the initial inoculation ratio, 219 which makes it difficult to form a stable community, and this instability is further amplified in large-scale fermentation.…”
Section: Discussion and Future Perspectivesmentioning
confidence: 99%
“…Efforts to construct a mutualistic relationship for the members of microbial consortia to form stable mutualistic consortia is a viable approach to improve these strategies. 216,220…”
Section: Discussion and Future Perspectivesmentioning
confidence: 99%
“…One of the practical bioengineering techniques widely recognized as a high-potential solution for the intensification of secondary plant metabolite production is in situ extraction [16][17][18][19]. Moreover, such a technique also provides a favorable microenvironment for the de novo production of secondary metabolites, which do not occur in the natural environment [20][21][22][23].…”
Section: Introductionmentioning
confidence: 99%
“…7−10 Since the content of free coniferyl alcohol in plants is relatively low, 11 microbial cell factories offer a promising approach to produce coniferyl alcohol and its high value-added derivatives. 4,12,13 Biosynthesis of coniferyl alcohol involves many promiscuous enzymes (Figure 1), including 4hydroxyphenylacetate 3-monooxygenase (HpaBC), 4-hydroxycinnamate:CoA ligase (4CL), cinnamoyl-CoA reductase (CCR), and cinnamyl alcohol dehydrogenase (CAD). 1 Through the screening of key enzymes, comparisons of fermentation medium, and the addition of ascorbic acid, engineered Escherichia coli could produce 187.7 mg/L coniferyl alcohol in a 5-L bioreactor.…”
Section: Introductionmentioning
confidence: 99%
“…5,11,19 However, eugenol could only be commercially obtained from plant extraction and is not cheap. 13 Hence, there is an urgent need to construct an economical coniferyl alcohol biosynthetic pathway. Some phenolic acids and monolignols can inhibit microbial growth, which is a limiting factor for the microbial synthesis of coniferyl alcohol, 20 and screening and the expression of efflux proteins are key to aromatic synthesis.…”
Section: Introductionmentioning
confidence: 99%